Literature DB >> 20392486

Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples.

Mohammed T Al-Samri, Andrea Benedetti, David Préfontaine, Ron Olivenstein, Catherine Lemière, Parameswaran Nair, James G Martin, Qutayba Hamid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20392486     DOI： 10.1016/j.jaci.2010.02.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  19 in total

Review 1.  Novel approaches to the management of noneosinophilic asthma.

Authors:  Neil C Thomson
Journal:  Ther Adv Respir Dis       Date:  2016-02-28       Impact factor: 4.031

Review 2.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

3.  Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis.

Authors:  Wendy C Moore; Annette T Hastie; Xingnan Li; Huashi Li; William W Busse; Nizar N Jarjour; Sally E Wenzel; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2013-12-09       Impact factor: 10.793

Review 4.  Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

Authors:  Ioana Agache; Cezmi A Akdis
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

5.  Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.

Authors:  Liesel D'silva; Nesreen Hassan; Hong-Yu Wang; Melanie Kjarsgaard; Ann Efthimiadis; Frederick E Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

6.  Baseline sputum eosinophil + neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort.

Authors:  Annette T Hastie; David T Mauger; Loren C Denlinger; Andrea Coverstone; Mario Castro; Serpil Erzurum; Nijar Jarjour; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Brenda Phillips; Sally E Wenzel; John V Fahy; Elliot Israel; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2020-02-05       Impact factor: 10.793

7.  Characterizing asthma from a drop of blood using neutrophil chemotaxis.

Authors:  Eric Karl-Heinz Sackmann; Erwin Berthier; Elizabeth A Schwantes; Paul S Fichtinger; Michael D Evans; Laura L Dziadzio; Anna Huttenlocher; Sameer K Mathur; David J Beebe
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 8.  The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.

Authors:  Stephanie S Eng; Magee L DeFelice
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

9.  Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program.

Authors:  Annette T Hastie; David T Mauger; Loren C Denlinger; Andrea Coverstone; Mario Castro; Serpil Erzurum; Nizar Jarjour; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Brenda R Phillips; Sally E Wenzel; John V Fahy; Elliot Israel; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2021-04-01       Impact factor: 21.405

10.  Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.

Authors:  Christopher E Brightling; Eugene R Bleecker; Reynold A Panettieri; Mona Bafadhel; Dewei She; Christine K Ward; Xiao Xu; Claire Birrell; René van der Merwe
Journal:  Lancet Respir Med       Date:  2014-09-07       Impact factor: 30.700
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.